As of 11:54am ET
| -0.0008 / -0.20%|
The 1 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +1,152.19% increase from the last price of 0.40.
The current consensus among 1 polled investment analysts is to Buy stock in Opexa Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.